Skip to main content
. 2022 Nov 17;14(22):5649. doi: 10.3390/cancers14225649
MSAF maximum somatic allele frequency;
bTMB blood-based tumor mutational burden
tTMB tissue-based tumor mutational burden
AF allele frequency
OS overall survival
PFS progression-free survival
HR hazard ratio
NSCLC non-small cell lung cancer
ICIs immune checkpoint inhibitors
GCGD Geneplus Cancer Genome Database
Ma-bTMB MSAF-adjusted bTMB
LAF-bTMB low allele frequency-bTMB
ITH intratumor heterogeneity
PD-1 programmed death 1
PD-L1 programmed death ligand 1
ctDNA circulating tumor DNA